Diagnosis and Clinical Presentation of Iliac Graft-Enteric Fistula: A Case Report
Launched by GOLESTAN UNIVERSITY OF MEDICAL SCIENCES · Aug 10, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding a serious condition called iliac graft-enteric fistula (IEF), which is an abnormal connection between the digestive system and major blood vessels. This can happen after certain medical procedures involving blood vessels. The study highlights a specific case of a 47-year-old man who experienced symptoms like vomiting blood and abdominal pain, leading to the diagnosis of this condition. Timely identification and treatment were crucial for him, showing how important it is for doctors to recognize this problem quickly.
Although this trial is not yet recruiting participants, it emphasizes the importance of awareness among healthcare professionals, especially for patients who have had vascular surgeries and experience gastrointestinal bleeding. By improving diagnosis and management of these rare but serious conditions, the goal is to reduce complications and improve patient outcomes. If you or someone you know has had recent vascular interventions and shows signs of gastrointestinal issues, it's important to talk to a healthcare provider about the possibility of this condition.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • n/a
- Exclusion Criteria:
- • n/a
About Golestan University Of Medical Sciences
Golestan University of Medical Sciences is a prominent academic and research institution located in Gorgan, Iran, dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on improving public health outcomes, the university collaborates with various national and international partners to conduct rigorous clinical studies that address critical health issues. Its commitment to excellence in medical education and research fosters an environment that encourages the development of new therapeutic interventions and the dissemination of knowledge to enhance patient care in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported